19min chapter

The Compound and Friends cover image

Michael Cembalest Returns

The Compound and Friends

CHAPTER

The Current State of Weight Loss Drugs and Rebranding as Cardiovascular Medications

The speakers discuss the effectiveness of weight loss drugs and the challenges of developing them in pill form. They explore the potential of rebranding these drugs as cardiovascular medications and discuss a study on their effectiveness in reducing cardiovascular risk. The chapter also touches on the differing perspectives between Wall Street and the medical community on the study's results.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode